YU259482A - Process for obtaining an agent for treating ulcers - Google Patents

Process for obtaining an agent for treating ulcers

Info

Publication number
YU259482A
YU259482A YU02594/82A YU259482A YU259482A YU 259482 A YU259482 A YU 259482A YU 02594/82 A YU02594/82 A YU 02594/82A YU 259482 A YU259482 A YU 259482A YU 259482 A YU259482 A YU 259482A
Authority
YU
Yugoslavia
Prior art keywords
obtaining
agent
treating ulcers
ulcers
treating
Prior art date
Application number
YU02594/82A
Other languages
English (en)
Inventor
A A Algieri
R R Grenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU259482A publication Critical patent/YU259482A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
YU02594/82A 1978-12-18 1982-11-19 Process for obtaining an agent for treating ulcers YU259482A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/970,517 US4200578A (en) 1978-12-18 1978-12-18 Thiazole derivatives

Publications (1)

Publication Number Publication Date
YU259482A true YU259482A (en) 1983-02-28

Family

ID=25517073

Family Applications (3)

Application Number Title Priority Date Filing Date
YU02921/79A YU292179A (en) 1978-12-18 1979-11-28 Process for obtaining an ulcer treating agent
YU02593/82A YU259382A (en) 1978-12-18 1982-11-19 Process for obtaining an agent for treating ulcers
YU02594/82A YU259482A (en) 1978-12-18 1982-11-19 Process for obtaining an agent for treating ulcers

Family Applications Before (2)

Application Number Title Priority Date Filing Date
YU02921/79A YU292179A (en) 1978-12-18 1979-11-28 Process for obtaining an ulcer treating agent
YU02593/82A YU259382A (en) 1978-12-18 1982-11-19 Process for obtaining an agent for treating ulcers

Country Status (24)

Country Link
US (1) US4200578A (xx)
JP (1) JPS5583768A (xx)
KR (3) KR830001920B1 (xx)
AT (1) AT375354B (xx)
AU (1) AU533014B2 (xx)
BE (1) BE880662A (xx)
CA (1) CA1133909A (xx)
CH (1) CH642956A5 (xx)
DE (1) DE2950838A1 (xx)
DK (1) DK533979A (xx)
ES (2) ES8101569A1 (xx)
FI (1) FI793904A (xx)
FR (1) FR2444674B1 (xx)
GB (1) GB2038822B (xx)
GR (1) GR73586B (xx)
HU (1) HU182461B (xx)
IE (1) IE49320B1 (xx)
IL (1) IL58960A (xx)
IT (1) IT1164076B (xx)
LU (1) LU82000A1 (xx)
NL (1) NL7909054A (xx)
SE (1) SE444680B (xx)
YU (3) YU292179A (xx)
ZA (1) ZA796814B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
GR71929B (xx) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
DE3486032T2 (de) * 1983-02-07 1993-05-19 Lilly Co Eli Synthese von nizatidin.
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
JPH0247453U (xx) * 1988-09-29 1990-03-30
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer
CN111974333B (zh) * 2020-08-19 2023-06-09 宁夏亚东化工有限公司 噻唑生产线及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
BE804144A (en) 1972-09-05 1974-02-28 Smith Kline French Lab H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"-(heterocyclyl-alkyl-(thio oxa amino or methylene-alkyl)-guanidines
US4083988A (en) * 1972-09-05 1978-04-11 Smith Kline & French Laboratories Limited Pharmacologically active compounds
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
KR830001263A (ko) 1983-04-29
FI793904A (fi) 1980-06-19
KR840004685A (ko) 1984-10-22
KR840004686A (ko) 1984-10-22
ES493718A0 (es) 1981-09-01
IT7950977A0 (it) 1979-12-04
AU533014B2 (en) 1983-10-27
DE2950838A1 (de) 1980-07-03
GR73586B (xx) 1984-03-26
CA1133909A (en) 1982-10-19
CH642956A5 (fr) 1984-05-15
KR840001075B1 (ko) 1984-07-31
SE444680B (sv) 1986-04-28
IL58960A0 (en) 1980-03-31
FR2444674A1 (fr) 1980-07-18
ATA793779A (de) 1983-12-15
ES487035A0 (es) 1980-12-16
DK533979A (da) 1980-06-19
IT1164076B (it) 1987-04-08
YU292179A (en) 1983-02-28
FR2444674B1 (fr) 1986-03-28
IL58960A (en) 1983-06-15
ES8106715A1 (es) 1981-09-01
ES8101569A1 (es) 1980-12-16
ZA796814B (en) 1980-11-26
US4200578A (en) 1980-04-29
KR830001920B1 (ko) 1983-09-23
LU82000A1 (de) 1980-07-21
KR840001074B1 (ko) 1984-07-31
AT375354B (de) 1984-07-25
IE49320B1 (en) 1985-09-18
AU5371679A (en) 1980-06-26
JPS639512B2 (xx) 1988-02-29
SE7910392L (sv) 1980-06-19
JPS5583768A (en) 1980-06-24
HU182461B (en) 1984-01-30
IE792436L (en) 1980-06-18
GB2038822A (en) 1980-07-30
BE880662A (fr) 1980-06-17
NL7909054A (nl) 1980-06-20
YU259382A (en) 1983-02-28
GB2038822B (en) 1983-01-19

Similar Documents

Publication Publication Date Title
GB2020269B (en) Cycloalkylatriazoles and process for obtaining same
YU93179A (en) Process for obtaining 4-deacetyl-vinca-leublastin c-3-carboxhydrazide
YU259482A (en) Process for obtaining an agent for treating ulcers
PH19618A (en) Process for preparing -2-pyrrolidone
YU271482A (en) Process for obtaining new flavanes
GB2037789B (en) Process and apparatus for demonomerizing polycapronamide
PH20118A (en) Method for the treatment of hyperlemia
YU241279A (en) Process for obtaining 2-chlorosulfinyl-azetidine-4-one
YU227679A (en) Process for obtaining n-benzylhaloacetamide deriatives
YU198879A (en) New process for obtaining benzothiazyl-disulfide
YU48279A (en) Process for preparing insecticidic and acaricidic compounds
GB2026360B (en) Dressing apparatus
YU112279A (en) Process for obtaining substituted dibenzylethers
DE2961469D1 (en) Process for treating wool
GB2025922B (en) Process for biodegradable effluent treatment
YU86879A (en) Process for obtaining 17-beta-carboxy-5-androstane-3-one
GB2030149B (en) Process for l- -glycerophosphate oxidase
YU94379A (en) Process for obtaining (z)-11-heptadecenyl-acetate and (z)-11-hexadecenyl-acetate
YU219379A (en) Process for obtaining new 1-benzoyl-3-thiosemicarbazide
HU177814B (en) Process for producing trisazo-colouring agent
YU178079A (en) Process for obtaining dietetics
YU304478A (en) Process for obtaining chloro-acetanilides
YU105179A (en) Process for obtaining new deoxyanthracyclins
YU258179A (en) New process for obtaining benzothiazole-sulfenamide
JPS5547860A (en) Germmkilling process